Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is uncertain whether being overweight, but not obese, is associated with advanced chronic kidney disease (CKD) and how the size and shape of associations between body-mass index (BMI) and advanced CKD differs among different types of people. METHODS: We used Clinical Practice Research Datalink records (2000-2014) with linkage to English secondary care and mortality data to identify a prospective cohort with at least one BMI measure. Cox models adjusted for age, sex, smoking and social deprivation and subgroup analyses by diabetes, hypertension and prior cardiovascular disease assessed relationships between BMI and CKD stages 4-5 and end-stage renal disease (ESRD). FINDINGS: 1,405,016 adults aged 20-79 with mean BMI 27.4kg/m2 (SD 5.6) were followed for 7.5 years. Compared to a BMI of 20 to <25kg/m2, higher BMI was associated with a progressively increased risk of CKD stages 4-5 (hazard ratio 1.34, 95% CI 1.30-1.38 for BMI 25 to <30kg/m2; 1.94, 1.87-2.01 for BMI 30 to <35kg/m2; and 3.10, 2.95-3.25 for BMI ≥35kg/m2). The association between BMI and ESRD was shallower and reversed at low BMI. Current smoking, prior diabetes, hypertension or cardiovascular disease all increased risk of CKD, but the relative strength and shape of BMI-CKD associations, which were generally log-linear above a BMI of 25kg/m2, were similar among those with and without these risk factors. There was direct evidence that being overweight was associated with increased risk of CKD stages 4-5 in these subgroups. Assuming causality, since 2000 an estimated 39% (36-42%) of advanced CKD in women and 26% (22-30%) in men aged 40-79 resulted from being overweight or obese. CONCLUSIONS: This study provides direct evidence that being overweight increases risk of advanced CKD, that being obese substantially increases such risk, and that this remains true for those with and without diabetes, hypertension or cardiovascular disease. Strategies to reduce weight among those who are overweight, as well as those who are obese may reduce CKD risk, with each unit reduction in BMI yielding similar relative reductions in risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Four large trials recruiting different types of patients with CKD have confirmed the safety of intensive LDL-C lowering with statins alone (atorvastatin, rosuvastatin, fluvastatin), or combining a moderate dose of simvastatin with ezetimibe.698,[701][702][703][704]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [698]
Experimental — accuracy not yet measuredIn the citing paper
“Statin-based therapy reduces the risk of major atherosclerotic events (i.e.coronary death, non-fatal MI, ischaemic stroke, and coronary revascularization) in patients with CKD, but does not meaningfully slow progression of CKD.248,[697][698][699]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [698]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Research works printed but not linked: 2
- Moody A. Health Survey for England 2013: Volume 1 Chapter 10: Adult anthropometric measures, overweight and obesity.
- National Institute of Clinical Excellence. (2014) Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. https://www.nice.org.uk/Guidance/cg182 (accessed 27th January 2017) 25340245
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationKalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationChronic kidney disease and the global NCDs agenda
Neuen, B. L., Chadban, S. J., Demaio, A. R., Johnson, D. W., & Perkovic, V. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000380 · Cited by 246
“As highlighted by World Kidney Day, obesity is a significant marker of risk for CKD, independent of hypertension and diabetes, and therefore represents another important target for CKD screening and early detection.(7) There is evidence that weight reduction in CKD reduces proteinuria and blood pressure and may slow d…”
BackgroundChang, A. R., Grams, M. E., Ballew, S. H., Bilo, H., Correa, A., Evans, M., Gutierrez, O. M., Hosseinpanah, F., Iseki, K., Kenealy, T., et al. (2019) · BMJ · doi:10.1136/bmj.k5301 · Cited by 233
Self-citationWilkinson, T. J., Miksza, J., Yates, T., Lightfoot, C. J., Baker, L. A., Watson, E. L., Zaccardi, F., & Smith, A. C. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12705 · Cited by 227
“This algorithm has previously been used to successfully identify those with ESRD in the UK Biobank.31 Participants identified with existing ESRD at baseline visit (either detected by hospital admission records or self-report) (‘prevalent ESRD’) were excluded from the analysis.”
MethodObesity and Kidney Function: A Two-Sample Mendelian Randomization Study
Kjaergaard, A. D., Teumer, A., Witte, D. R., Stanzick, K. J., Winkler, T. W., Burgess, S., & Ellervik, C. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab249 · Cited by 117
Obesity‐associated glomerular inflammation increases albuminuria without renal histological changes
Mima, A., Yasuzawa, T., King, G. L., & Ueshima, S. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12400 · Cited by 85
Conventional and genetic evidence on the association between adiposity and CKD
Zhu, P., Herrington, W. G., Haynes, R., Emberson, J., Landray, M. J., Sudlow, C. L. M., Woodward, M., Baigent, C., Lewington, S., & Staplin, N. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050679 · Cited by 83
Self-citationFritz, J., Brozek, W., Concin, H., Nagel, G., Kerschbaum, J., Lhotta, K., Ulmer, H., & Zitt, E. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021091263 · Cited by 70
“4 million people with similar baseline characteristics as in our study.(28) This fact becomes even more important considering the growing number of obese individuals worldwide, with the prevalence of obesity having more than doubled since 1980 in .”
BackgroundNeuen, B. L., Weldegiorgis, M. T., Herrington, W. G., Ohkuma, T., Smith, M. C., & Woodward, M. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.02.335 · Cited by 71
Self-citationGLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity
Abasheva, D., Ortíz, A., & Fernández‐Fernández, B. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae296 · Cited by 70
Ou, Y.-L., Lee, M.-Y., Lin, I.-T., Wen, W.-L., Hsu, W.-H., & Chen, S.-C. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1969247 · Cited by 68
“Previous studies have reported an association between high BMI and the risk of ESRD in the general population [16,17].”
BackgroundEducational level and risk of chronic kidney disease: longitudinal data from the PREVEND study
Thio, C. H. L., Vart, P., Kieneker, L. M., Snieder, H., Gansevoort, R. T., & Bültmann, U. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy361 · Cited by 67
“current smoking[28], higher alcohol consumption, higher Na excretion[29], lower K excretion[17], lower Mg excretion[30], higher estimated protein intake[31], higher BMI[32], higher WHR[33], diabetes, hypertension, and hypercholesterolemia).”
BackgroundEbrahim, Z., Proost, S., Tito, R. Y., Raes, J., Glorieux, G., Moosa, M. R., & Blaauw, R. (2022) · Nutrients · doi:10.3390/nu14040805 · Cited by 69
“Obesity (35.5%), highly prevalent in participants, has been linked with the progression of CKD [68].”
InfluentialHydes, T., Kennedy, O. J., Buchanan, R. M., Cuthbertson, D. J., Parkes, J., Fraser, S. D., & Roderick, P. J. (2023) · BMC Medicine · doi:10.1186/s12916-023-02891-x · Cited by 59
“The principles utilised by the algorithm have previously been used successfully [30].”
MethodNazzal, Z. A. S., Hamdan, Z. I., Masri, D., Abu-Kaf, O., & Hamad, M. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02138-4 · Cited by 64
Basolo, A., Salvetti, G., Giannese, D., Genzano, S. B., Ceccarini, G., Giannini, R., Sotgia, G., Fierabracci, P., Piaggi, P., & Santini, F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad330 · Cited by 53
Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study
Wang, J., Niratharakumar, K., Gokhale, K. M., Tahrani, A. A., Taverner, T., Thomas, G. N., & Dasgupta, I. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.05.008 · Cited by 58
“4 million participants from English general practice showed a higher risk of CKD with higher BMI over 25 kg/m(2); the log-linear relationship between the 2 remained even after adjusting for prior diabetes, hypertension, and history of cardiovascular disease.(42)”
BackgroundManagement of obesity across women's life course: FIGO Best Practice Advice
Maxwell, C. V., Shirley, R., O'Higgins, A. C., Rosser, M. L., O’Brien, P., Hod, M., O'Reilly, S. L., Medina, V. P., Smith, G. N., Hanson, M. A., et al. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14549 · Cited by 50
Interventions for weight loss in people with chronic kidney disease who are overweight or obese
Conley, M. M., McFarlane, C. M., Johnson, D. W., Kelly, J. T., Campbell, K. L., & MacLaughlin, H. L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013119.pub2 · Cited by 49
Chronic kidney disease in Cameroon: a scoping review
Aseneh, J. B., Kemah, B., Mabouna, S., Njang, E., Ekaney, D. S. M., & Agbor, V. N. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02072-5 · Cited by 45
Hansrivijit, P., Puthenpura, M. M., Ghahramani, N., Thongprayoon, C., & Cheungpasitporn, W. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02699-1 · Cited by 44
Godoy‐Matos, A. F., Valério, C. M., Júnior, W. S. D. S., Neto, J. M. D. A., Sposito, A. C., & Suassuna, J. H. R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01796-4 · Cited by 50
“For instance, in a cohort of 1,405,016 adults from English primary care records, the risk of developing advanced CKD increased in a log-linear fashion with rising BMI, from overweight to obesity to severe obesity, regardless of the presence of T2D, hypertension, or CVD [91].”
Pinto, K. R. D., Feckinghaus, C. M., & Hirakata, V. N. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x202010022 · Cited by 43
“Second, calibration of dipstick urinalysis and creatinine laboratory tests differed between studies and even in each study there may have been differences in techniques, despite the established parameters to consider normality (21).”
MethodWeldegiorgis, M. T., & Woodward, M. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02932-2 · Cited by 47
“It included 1,405,016 individuals from the CPRD database with a valid BMI measurement at any time between January 2000 and March 2014 [18, 19].”
BackgroundMethodInfluentialSelf-citationWeldegiorgis, M. T., Smith, M. C., Herrington, W. G., Bankhead, C. R., & Woodward, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz059 · Cited by 42
Self-citationYu, Z., Grams, M. E., Ndumele, C. E., Wagenknecht, L. E., Boerwinkle, E., North, K. E., Rebholz, C. M., Giovannucci, E. L., & Coresh, J. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.07.025 · Cited by 31
Self-citationTurer, C. B., Baum, M. G., Dubourg, L. D., Selistre, L. D. S., & Skinner, A. C. (2019) · Obesity Science & Practice · doi:10.1002/osp4.365 · Cited by 29
Jin, J., Woo, H., Jang, Y., Lee, W., Kim, J., Lee, I., Park, K., & Choi, Y. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0099 · Cited by 29
Ruzangi, J., Iwagami, M., Smeeth, L. L., Mangtani, P., & Nitsch, D. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02065-4 · Cited by 28
Bilson, J., Hydes, T., McDonnell, D., Buchanan, R. M., Scorletti, E., Mantovani, A., Targher, G., & Byrne, C. D. (2024) · Liver International · doi:10.1111/liv.16159 · Cited by 31
Kefeni, B. T., Hajito, K. W., & Getnet, M. (2021) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s301748 · Cited by 27
“This finding is concordant with studies conducted in Brazil, 11 Washington, 24 London, 25 and Turkey.”
Zhu, P., Lewington, S., Haynes, R., Emberson, J., Landray, M., Cherney, D. Z. I., Woodward, M., Baigent, C., Herrington, W. G., & Staplin, N. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0642-3 · Cited by 26
Self-citationSeverity and Duration of Acute Kidney Injury and Chronic Kidney Disease after Cardiac Surgery
Choe, S. H., Cho, H.-Y., Bae, J., Ji, S., Yoon, H., Lee, H., Lee, J. H., Kim, J., & Kim, W. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081556 · Cited by 24
“body mass index and history of diabetes mellitus were also significant in our study; both are known risk factors of CKD in the general population [25,26].”
BackgroundThe New Challenge of Obesity - Obesity-Associated Nephropathy
Hao, M., Lv, Y., Liu, S. J., & Guo, W. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s433649 · Cited by 26
“11 Another 14-year cohort study from Korean adults showed that high baseline levels of BMI and waist-to-hip ratio were independent risk factors for the development of CKD, and obesity was associated with the incidence of CKD. 12 The fact that BMI is associated with obesity-related kidney injury is…”
BackgroundMontgomery, J. R., Waits, S. A., Dimick, J. B., & Telem, D. A. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003627 · Cited by 26
“Intensive medical therapy is rarely successful for long-term weight loss among any adult population, and persistent obesity with BMI >35 kg/m(2) has been prospectively shown to predict worsening kidney disease over time.(16,38,39) Should these patients’ kidney disease later progress to end-stage kidney disease, persis…”
BackgroundRecent advances in the treatment of patients with obesity and chronic kidney disease
Wahab, R. A., COHEN, R. V., & le Roux, C. W. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2203517 · Cited by 25
“Furthermore, obesity and CKD were associated in individuals with and without diabetes, hypertension and cardiovascular disease [16], indicating that obesity may partly mediate CKD risk via mechanisms independent of its effects on T2D and cardiovascular disease risks.”
BackgroundÖzbek, L., Abdel‐Rahman, S. M., Unlu, S., Güldan, M., Çöpür, S., Burlacu, A., Covic, A. C., & Kanbay, M. (2024) · Medicina · doi:10.3390/medicina60101668 · Cited by 25
“…adults aged 20–79 found that higher BMI levels, starting from overweight (BMI 25 to 30 kg/m 2 ) and increasing to obesity (BMI ≥ 30 kg/m 2 ), were consistently associated with progressively increased risks of advanced CKD stages 4–5, with a particularly pronounced risk at a BMI ≥ 35 kg/m 2 [16].”
BackgroundHamilton, S., Nakanga, W. P., Prynn, J. E., Crampin, A. C., Fecht, D., Vineis, P., Caplin, B., Pearce, N. E., & Nyirenda, M. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02034-x · Cited by 20
Sullivan, M. K., Lees, J. S., Rosales, B. M., Cutting, R., Wyld, M. L. R., Woodward, M., Webster, A. C., Mark, P. B., & Mata, N. L. D. L. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.05.007 · Cited by 20
“• To allow the identification of incident KRT, the blood results had to precede long-term KRT (kidney transplantation or maintenance dialysis: identified from linked hospital records using an established algorithm 10 ).”
Self-citationEffects of Obesity on Postoperative Complications and Graft Survival After Kidney Transplantation
Fellmann, M., Balssa, L., Clément, E., Frey, P., Frontczak, A., Bernardini, S., Chabannes, É., Guichard, G., Bittard, H., & Kleinclauss, F. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2020.02.178 · Cited by 18
Anand, S., Zheng, Y., Montez‐Rath, M. E., Wei, W. J., Perico, N., Carminati, S., Narayan, K. M. V., Tandon, N., Mohan, V., Jha, V., et al. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000453 · Cited by 17
Issues in Measuring and Interpreting Diet and Its Contribution to Obesity
Taylor, R., Haslam, R. L., Burrows, T. L., Duncanson, K., Ashton, L., Rollo, M. E., Shrewsbury, V. A., Schumacher, T. L., & Collins, C. E. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00336-2 · Cited by 18
Smith, M. C., Herrington, W. G., Weldegiorgis, M. T., Hobbs, R. F., Bankhead, C. R., & Woodward, M. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.04.004 · Cited by 16
Self-citationSchubert, C. R., Paulsen, A. J., Nondahl, D. M., Dalton, D. S., Fischer, M., Klein, R., Klein, R., Tweed, T. S., & Cruickshanks, K. J. (2018) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2018.0041 · Cited by 15
Rwegerera, G. M., Molefe‐Baikai, O. J., Masaka, A., Shimwela, M., Rivera, Y. P., Oyewo, T. A., Godman, B., Massele, A. Y., & Habte, D. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1506674 · Cited by 16
“The remaining studied factors including gender, marital status, BMI, type of DM, glycemic control and HIV status were not associated with CKD (Table 3).”
BackgroundInfluentialSu, D., Zhang, X., He, K., Chen, Y., & Wu, N. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.998549 · Cited by 14
Taqanaki, P. B., Tanbakuchi, D., Afzalaghaee, M., Ghayour‐Mobarhan, M., & Esmaily, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-83973-5 · Cited by 13
Shirsat, P. D., Balachandran, M., Chamarthi, V. S., & Sonavane, K. (2025) · Journal of CardioRenal Medicine · doi:10.3390/jcrm1010004 · Cited by 17
“Studies have reported severe adverse renal outcomes, such as progression to ESRD or CKD-related mortality, in people with a BMI ≥ 25 kg/m 2 [15–17].”
Houser, M. C., Smith, D. J., Rhodes, D., Glick-Smith, J. L., Chovan, P., Ferranti, E. P., Dunbar, S. B., Tansey, M. G., Hertzberg, V., & Mac, V. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114107 · Cited by 16
The impact of chronic kidney disease on bariatric perioperative outcome: a MBSAQIP matched analysis
Mazzei, M. M., Zhao, H., & Edwards, M. A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.07.013 · Cited by 13
Moreira, A. D., Velásquez-Meléndez, G., Ladeira, R. M., da Silva, G. B., da Fonseca, M. D. J. M., & Barreto, S. M. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1878968 · Cited by 12
Obesity and Chronic Kidney Disease: The Dual Epidemic in Cardiovascular Health
Grant, C. H., & Bell, S. (2025) · European Cardiology Review · doi:10.15420/ecr.2025.33 · Cited by 12
Relation of glomerular filtration to insulin resistance and related risk factors in obese children
Magen, D., Halloun, R., Galderisi, A., Caprio, S., & Weiss, R. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01001-2 · Cited by 10
Approaches to patients with obesity and CKD: focus on nutrition and surgery
Bellizzi, V., Annunziata, G., Albanese, A., D’Alessandro, C., Garofalo, C., Foletto, M., Barrea, L., Cupisti, A., Zoccali, C., & Nicola, L. D. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae291 · Cited by 13
“Several studies have suggested the role of obesity in the progression of kidney disease in adults and adolescents [12 –15 ].”
Choi, Y., Jacobs, D. R., Kramer, H., Shroff, G. R., Chang, A. R., & Duprez, D. A. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.12.001 · Cited by 9
Reitzinger, S., & Czypionka, T. (2024) · BMC Public Health · doi:10.1186/s12889-024-19574-8 · Cited by 8
Spielmann, J., Naujoks, W., Emde, M., Allweyer, M., Kielstein, H., Quandt, D., & Bähr, I. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.585693 · Cited by 10
Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
Steele, C. N., & Nowak, K. L. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2010013 · Cited by 10
“Higher BMI is associated with increased risk for incident of CKD and advanced CKD (Stage 4–5; eGFR ≤ 29 mL/min/1.73 m 2 ) [18,33,34,40].”
BackgroundInfluentialUemura, T., Nishimoto, M., Eriguchi, M., Tamaki, H., Tasaki, H., Furuyama, R., Fukata, F., Kosugi, T., Morimoto, K., Matsui, M., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15347 · Cited by 8
Sahi, G., Reid, J., Moist, L., Chiu, M., Vinson, A., Stranges, S., Naylor, K., Zhu, Y., & Clemens, K. K. (2024) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581241293199 · Cited by 7
Anthropometry-based Body Fat Percentage Predicts High hs-CRP in Chronic Kidney Disease Patients
Thaha, M., Empitu, M. A., Kadariswantiningsih, I. N., Nugroho, C. W., Hasanatuludhhiyah, N., Rasyid, H., El-Hakim, Z. F., Suryansyah, M. M., Alda, R. R., Alsagaff, M. Y., et al. (2018) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v10i2.397 · Cited by 8
“, which concluded that BMI >25 kg/m2 was associated with a progressively increased risk of CKD stages 4-5.(19) Prior studies also found high prevalence of overweight and obesity in predialysis and CKD patients.”
BackgroundWahyuni, T., Lianawati, L., Harianto, J. W., & Khusnal, E. (2020) · Electronic Journal of General Medicine · doi:10.29333/ejgm/7808 · Cited by 8
Interventions for weight loss in people with chronic kidney disease who are overweight or obese
Conley, M. M., McFarlane, C. M., MacLaughlin, H. L., Johnson, D. W., & Campbell, K. L. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013119 · Cited by 7
Ten tips on how to manage obesity in the presence of CKD
Kaesler, N., & Fleig, S. V. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae317 · Cited by 7
Ileal conduit versus neobladder: A propensity score‐matched analysis of the effect on renal function
Iqbal, U. H., Houenstein, H., Elsayed, A. S., Jing, Z., James, G., Hussein, A. A., & Guru, K. A. (2021) · International Journal of Urology · doi:10.1111/iju.14747 · Cited by 7
Sutadji, J. T., Pranoto, A. S., & Prasetyo, R. V. (2023) · JUXTA Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga · doi:10.20473/juxta.v14i12023.12-16 · Cited by 9
Cardiometabolic Risk Indicators for Kidney Disease in Mexican Patients with Type 2 Diabetes
López, L. V., Hernández-Sánchez, R., Roy-García, I. A., Muñoz-Torres, A. V., Medina‐Bravo, P., & Escobedo, J. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.08.003 · Cited by 7
Nadkarni, G. N., Fei, K., Galarneau, G., Gao, Y. L., Wilson, J. G., Cooper, R., Madden, E. B., Denny, J. C., Richardson, L. D., Pollak, M. R., et al. (2021) · Medicine · doi:10.1097/md.0000000000027785 · Cited by 16
“Although BMIrelated traits and kidney disease are correlated,([37]) the association of heterozygous APOL1 variants with obesity-related traits may represent true pleiotropy of APOL1 risk variants and indicate that their impact on ancestry-related disparities may extend beyond renal phenotypes.”
BackgroundInfluence of metabolic disorders on the development of renal pathology
Bashkinov, R. A., Батлук, Т. И., Мельников, Е. С., Trubnikova, M. A., & Arutyunov, A. G. (2022) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2022-3-2-7-18 · Cited by 5
Chen, S., Zhang, T., Gao, H., & Zhang, J. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2461682 · Cited by 6
Cave, E. M., Prigge, K. L., Crowther, N. J., George, J. A., & Padoa, C. J. (2020) · Kidney & Blood Pressure Research · doi:10.1159/000511213 · Cited by 5
Papantoniou, P., & Maniadakis, N. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1690211 · Cited by 4
Fujimoto, K., Kikuchi, M., Nakai, M., Konta, T., Iseki, K., Tsuruya, K., Yamagata, K., Narita, I., Moriyama, T., Shibagaki, Y., et al. (2025) · Clinical and Experimental Nephrology · doi:10.1007/s10157-025-02800-x · Cited by 6
“Hypertension [3], diabetes [4, 5], obesity [6, 7], all of which have been identified as risk factors for kidney damage in multiple previous studies, and correction of these factors is a component of treatment.”
Kim, Y.-J., Oh, S., Lim, J., Cho, J., Jung, H., Kim, C., Park, S.-H., Kwon, T., & Kim, Y.-L. (2023) · Nutrients · doi:10.3390/nu15234959 · Cited by 4
“The mechanism underlying renal function deterioration in obese patients with CKD remains unclear despite obesity being a well-documented risk factor for kidney damage [3,4].”
BackgroundAlmanaa, M. A., Alahmad, H. N., Alarifi, M., Alenazi, K., Abanomy, A., Alneghaimishi, K., Alshamrani, B., & Albathi, R. (2024) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/192995 · Cited by 4
“The global prevalence of overweight and obesity has increased awareness of the connections between various health conditions and BMI, including chronic kidney disease [10–12].”
BackgroundTassew, W. C., Zeleke, A. M., Ferede, Y. A., & Ayenew, G. M. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04011-8 · Cited by 4
“%) report lower prevalence rates of kidney dysfunction [9, 55, 56].”
Gökten, D. B., Tezcan, M. E., Yağız, B., Erden, A., Kimyon, G., Bilge, N. Ş. Y., Kılıç, L., Coşkun, B. N., Ersözlü, E. D., Küçükşahin, O., et al. (2025) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70274 · Cited by 4
“Furthermore, patients in the CKD group had a higher mean age, longer disease duration, and increased BMI—all of which are established risk factors for the development and progression of CKD [46].”
High Rates of Multimorbidity Reported Among People of Color Despite Healthy Weight
Jackson, C. T., Young, J. C., & Onsando, W. M. (2022) · Health Equity · doi:10.1089/heq.2022.0074 · Cited by 5
“Likewise, the National Kidney Foundation report a strong association between weight and kidney disease,(22) and results from a very large study of over 1 million adults living in United Kingdom found a direct link between increased BMI and risk of chronic kidney disease, independent of other risk factors or chronic co…”
BackgroundOlajide, T. H., Raji, Y. R., Ademola, S. A., Dele-Alimi, T. O., Oluwaseye, A., Ayomide, O., Ajani, H. O., Abdulkareem, M. A., & Amodu, O. K. (2023) · Human Gene · doi:10.1016/j.humgen.2023.201146 · Cited by 5
Platform-dependent effects of genetic variants on plasma APOL1
(2026) · doi:10.1016/j.isci.2026.114953 · Cited by 3
“While this cross-cohort approach strengthens replicated signals, it complicates the interpretation of non-replicating signals, which may be attributable to factors unrelated to the proteomic platform.”
Indurain, A., Karlsson, M., Fernström, A., Uhlin, F., Linge, J., Petersson, M., Leinhard, O. D., & Segelmark, M. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101164 · Cited by 3
Obesity and Its Clinical Implications in End-Stage Kidney Disease
Petrulienė, K., Žilinskienė, A., Vaičiūnienė, R., Vaičiūnas, K., Bumblytė, I. A., & Dalinkevičienė, E. (2026) · Medicina · doi:10.3390/medicina62010211 · Cited by 3
“Previous studies have documented serious adverse renal outcomes, including progression to ESKD or death related to chronic kidney disease, among individuals with a BMI ≥ 25 kg/m 2 , with the risk rising markedly when BMI exceeds 30 kg/m 2 [10–13].”
Jaggers, J. R., Kindred, M. M., Porterc, R., Sui, X., Lavie, C. J., & Prasad, V. K. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.06.007 · Cited by 4
Ebrahim, Z., Moosa, M. R., & Blaauw, R. (2020) · Nutrients · doi:10.3390/nu12123608 · Cited by 4
“An increased body mass index (BMI) above 25 kg/m2 has recently been associated with a progressively increased risk of CKD stages 4 to 5 [5].”
BackgroundResultLinee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici
Marx, N., Federici, M., Schütt, K. S., Müller‐Wieland, D., Ajjan, R., Antunes, M. J., Christodorescu, R., Crawford, C. A., Angelantonio, E. D., Eliasson, B., et al. (2024) · Giornale Ialiano di Cardiologia · doi:10.1714/4162.41558 · Cited by 6
Self-citationWorld Kidney Day: a call to action for chronic kidney disease prevention and multidisciplinary care
Alfieri, C., Consoli, R., Soloperto, S., & Caldiroli, L. (2025) · Giornale di Clinica Nefrologica e Dialisi · doi:10.33393/gcnd.2025.3512 · Cited by 3
Li, S., Zhang, Y., & Wei, W. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103381 · Cited by 5
Raikou, V. D., & Gavriil, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.017 · Cited by 5
Platform-dependent effects of genetic variants on plasma APOL1
Wang, Q. S., Huang, J., Chan, L., Haste, N., Olsson, N., Gaun, A., McAllister, F., Madhireddy, D., Baruch, A., Cardone, K. M., et al. (2025) · doi:10.1101/2025.01.30.635763 · Cited by 3
Wang, J., Xiao, X., Zhang, H., Wu, D., Luo, F., & Yu, J. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01466-0 · Cited by 2
“This association might result from systemic and intraglomerular hypertension, the effect of prediabetes concentrations of blood glucose on podocyte stress, and other unrecognized factors [26].”
Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis
Han, M., Lin, W., Cao, Y., Murray, P., Wilm, B., McWilliam, S. J., Curran, J., & Xie, R. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500550 · Cited by 4
Inflammation and the long-term incidence of hypertension in women
Adamstein, N. H., Moorthy, M. V., Cook, N. R., Buring, J. E., Sesso, H. D., & Ridker, P. M. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag426 · Cited by 2
Determining the Possible Effect of Diabetes on the Nutritional Status of Hemodialysis Patients
Çelik, Z. M., Akduman, G., ÖZEN, H., DAŞDEMİR, Ş., & Güneş, F. E. (2021) · Journal of International Health Sciences and Management · doi:10.48121/jihsam.910490 · Cited by 3
“Journal of International Health Sciences and Management, 7(14):34-41.”
BackgroundInfluentialYang, Y.-M., & Choi, E. J. (2022) · Medicine · doi:10.1097/md.0000000000031014 · Cited by 2
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease
Cejka, V., Störk, S., Nadal, J., Schmid, M. C., Sommerer, C., Sitter, T., Meiselbach, H., Busch, M., Schneider, M. P., Saritas, T., et al. (2023) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2023.04.006 · Cited by 3
Johns, T. S., Estrella, M. M., Hébert, J. R., Franceschini, N., Larson, J. C., Boulware, L. E., Snetselaar, L., Golestaneh, L., Shadyab, A. H., Shivappa, N., et al. (2025) · Kidney360 · doi:10.34067/kid.0000000801 · Cited by 2
Lithium and the living kidney donor: Science or stigma?
Davis, R. A., Branagan, W. T., Schneck, C. D., Schold, J. D., Thant, T., & Kaplan, B. E. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.05.022 · Cited by 1
Huang, X., Liang, J., Zhang, J., Fu, J., Deng, S., Xie, W., & Zheng, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-19532-4 · Cited by 2
“Consistent with previous findings, our results indicated that lower body mass index was related to decreased risk of CCV-KD [27].”
Result
Metadata
- Authors
- Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M.
- Affiliations
- Churchill Hospital (GB)
- University of Oxford (GB)
- Johns Hopkins University (US)
- The University of Sydney (AU)
- Corresponding author
- Herrington, William G.
- Bankhead, Clare
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-03-08
- Volume
- 12
- Issue
- 3
- Pages
- e0173515
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5342319
- OpenAlex
- W2593429896
- Cited by
- 141
- References
- 63
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 23 · 2023: 16 · 2022: 12 · 2021: 17 · 2020: 23 · 2019: 7 · 2018: 9 · 2017: 2
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute for Health Research
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- body mass index, overweight, obesity, advanced chronic kidney disease, end-stage renal disease, weight loss, diabetes mellitus, hypertension, cardiovascular disease, smoking, sex differences, primary care cohort, Clinical Practice Research Datalink, kidney disease prevention, England, United Kingdom, social deprivation, cardiovascular risk factors
- MeSH terms
- Adult, Aged, England, Female, Humans, Male, Middle Aged, Obesity, Population Surveillance, Primary Health Care, Prospective Studies, Risk Factors, Comorbidity, Body Mass Index, Proportional Hazards Models, Risk Assessment, Overweight, Renal Insufficiency, Chronic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.